menu-search
LEXISNEXIS_ICON4_SIGNINSign-in LEXISNEXIS_ICONS_SUPPORTHelp

Post-market

View Life Sciences by content type:

News
Practice notes
Precedents
Q&As

Latest Life Sciences News

TCC grants AA 1996, s 9 stay applying the presumption in favour of ‘one stop adjudication’ in multi-contract scenario (Surrey County Council v Suez Recycling and Recovery Surrey)

TCC grants AA 1996, s 9 stay applying the presumption in favour of ‘one stop adjudication’ in multi-contract scenario (Surrey County Council v Suez Recycling and Recovery Surrey)

TCC grants AA 1996, s 9 stay applying the presumption in favour of ‘one stop adjudication’ in multi-contract scenario (Surrey County Council v Suez Recycling and Recovery Surrey)

Life Sciences weekly highlights—22 July 2021

Life Sciences weekly highlights—22 July 2021

The following Life Sciences news provides comprehensive and up to date legal information on Life Sciences weekly highlights—22 July 2021

Brexit SI Bulletin—latest drafts and sifting committee reports, 16 July 2021

Brexit SI Bulletin—latest drafts and sifting committee reports, 16 July 2021

The following Life Sciences news provides comprehensive and up to date legal information on Brexit SI Bulletin—latest drafts and sifting committee reports, 16 July 2021

Life Sciences weekly highlights—15 July 2021

Life Sciences weekly highlights—15 July 2021

The following Life Sciences news provides comprehensive and up to date legal information on Life Sciences weekly highlights—15 July 2021

Featured Life Sciences content

Joint, several, and joint and several liability

Joint, several, and joint and several liability

Joint, several, and joint and several liabilityContractWhere a contract is made by two or more parties it may contain a promise or obligation made by...

Conditions precedent in commercial contracts

Conditions precedent in commercial contracts

Conditions precedent in commercial contractsThis Practice Note considers the meaning and use of conditions precedent in commercial arrangements. It...

Sub-licensing intellectual property rights

Sub-licensing intellectual property rights

An intellectual property (IP) owner may choose to license its IP to a third party. This can be an effective route to generating revenue while...

Co-operative and community benefit societies

Co-operative and community benefit societies

Co-operative and community benefit societiesWhat is a co-operative or community benefit society?A co-operative society or community benefit society...

Practice notes

Rome II—application and interpretation

Rome II—application and interpretationThis Practice Note is for use when determining applicable law in respect of events giving rise to damage, where...
Read More >
19th May
Q&As

Can a third party rely on ostensible/apparent authority where they know the person signing a document is an employee of a company not a director and they sign as a director and in the name of that director?

Can a third party rely on ostensible/apparent authority where they know the person signing a document is an employee of a company not a director and...
Read More >
19th May
Practice notes

Brexit—exiting the EU under Article 50 [Archived]

Brexit—exiting the EU under Article 50 [Archived]ARCHIVED: This Practice Note has been archived and is not maintained.This Practice Note contains...
Read More >
Produced in partnership with Adam Cygan of University of Leicester 19th May
tag iconBrexit
Practice notes

Antibiotic drug Nitrofurantoin (AMCo, Morningside Healthcare, Morningside Pharmaceuticals and Alliance Healthcare) (50507)

Antibiotic drug Nitrofurantoin (AMCo, Morningside Healthcare, Morningside Pharmaceuticals and Alliance Healthcare) (50507)CASE HUB See further,...
Read More >
19th May
Q&As

Can the board of a co-operative and community benefit society (a registered society) delegate powers to any third party, and can the registered society grant a power of attorney to a third party to execute documents on its behalf?

Can the board of a co-operative and community benefit society (a registered society) delegate powers to any third party, and can the registered...
Read More >
19th May
Practice notes

Rome Convention—introduction and interpretation [Archived]

Rome Convention—introduction and interpretation [Archived]ARCHIVED: This Practice Note has been archived and is not maintained.The UK is no longer...
Read More >
19th May
Precedents

Force majeure clause

Coronavirus (COVID-19): In addition to the below content on force majeure generally, see also: • Coronavirus (COVID-19)...
Read More >
19th May
tag iconCOVID-19 tag iconIn-house
Practice notes

Managing a breach of confidentiality or information security

Many companies and government bodies (such as HMRC) have been exposed to loss of confidential information and many other breaches of confidentiality...
Read More >
19th May
Practice notes

Introduction to retained EU law

Introduction to retained EU lawThis Practice Note provides an introduction to retained EU law. It provides an overview of the key definitions and...
Read More >
Produced in partnership with Dr. Kieran Laird of Gowling WLG 19th May
tag iconBrexit
Precedents

Counterparts clause

1 Counterparts—agreement 1.1 This agreement may be signed in any number of separate counterparts, each of which when...
Read More >
19th May
tag iconIn-house
Practice notes

Model ADR clauses

Model ADR clausesThis Practice Note considers model form alternative dispute resolution (ADR) clauses provided by a number of service providers,...
Read More >
19th May
Precedents

Execution clause—company—contract

Option 1—contract signed on behalf of a company, where the authorised signatory is an individual Signed by [insert name of...
Read More >
19th May
tag iconIn-house
Practice notes

Requirements of the company seal

Requirements of the company sealThis Practice Note provides practical guidance regarding the requirements of the company seal. Where a company has a...
Read More >
19th May
Practice notes

Brexit implementation period—enforcement [Archived]

Brexit implementation period—enforcement [Archived]ARCHIVED: This Practice Note has been archived and is not maintained.This Practice Note considers...
Read More >
19th May
tag iconBrexit
Practice notes

Subcontracting

SubcontractingThis Practice Note examines the following legal and practical matters in relation to entering into a subcontract or when granting...
Read More >
19th May
Practice notes

Parallel imports

ScopeThis Practice Note explains trade mark law on parallel trade. Parallel imports, or ‘grey market’ goods, are genuine goods that are placed on the...
Read More >
Produced in partnership with Taylor Wessing LLP 19th May

Most recent Post-market content

Practice notes

Pharmaceutical trade marks and parallel imports

Pharmaceutical trade marks and parallel importsAt 11 pm on 31 December 2020 (IP completion day), the UK ceased to be subject to EU law. The UK’s...
Read More >
Produced in partnership with Oscar Benito of Gavi, the Vaccines Alliance 25th Jul
Practice notes

Pharmacovigilance

PharmacovigilancePharmacovigilance is the process of collecting and understanding information relating to the adverse effects of medicinal product...
Read More >
Produced in partnership with Eveline Van Keymeulen of Allen & Overy LLP and Jeanne Fabre of Allen & Overy LLP 25th Jul
Practice notes

Parallel imports

Parallel importsScopeThis Practice Note explains trade mark law on parallel trade. Parallel imports, or ‘grey market’ goods, are genuine goods that...
Read More >
Produced in partnership with Taylor Wessing LLP 25th Jul
Practice notes

Product liability in the life sciences sector

Product liability in the life sciences sectorThe UK regulatory framework for product liability has mainly originated from EU law. Many principles and...
Read More >
25th Jul
Practice notes

What does IP completion day mean for medicinal products?

What does IP completion day mean for medicinal products?11 pm (GMT) on 31 December 2020 marked the end of the implementation period put in place to...
Read More >
25th Jul
Practice notes

Brexit—implications of the Withdrawal Agreement for the life sciences sector [Archived]

Brexit—implications of the Withdrawal Agreement for the life sciences sector [Archived]ARCHIVED: This Practice Note has been archived and is not...
Read More >
25th Jul
tag iconBrexit
Practice notes

Anti-counterfeiting in the UK

Anti-counterfeiting in the UKThis Practice Note summarises the main types of legal action that can be taken against the UK trade in counterfeit goods,...
Read More >
Produced in partnership with Taylor Wessing LLP 25th Jul
Practice notes

Falsified medicines

Falsified medicinesA worldwide problem, for developed and developing countries alike, is the trade of falsified medicinal products. The terms...
Read More >
Produced in partnership with Elisabethann Wright of Cooley LLP and Fabien Roy, Jane Summerfield, Alexander Wenzel, Hélène Boland, Hannah Kerr-Peterson, Jessica Koffel and Silvia Lopez Arnao of Hogan Lovells 25th Jul
Practice notes

Sale of counterfeit goods online

Sale of counterfeit goods onlineIP COMPLETION DAY: 11pm (GMT) on 31 December 2020 marks the end of the Brexit transition/implementation period entered...
Read More >
25th Jul
Q&As

What are the obligations that a QPPV must perform?

What are the obligations that a QPPV must perform?Article 104(3) of Directive 2001/83/EC (consolidated version 26.07.2019), the Pharmaceutical Code...
Read More >
25th Jul
Q&As

Does a marketing authorisation holder (MAH) of a medicinal product need to collect information on individual cases of ‘off-label’ use if there is no adverse reaction? If so, how?

Does a marketing authorisation holder (MAH) of a medicinal product need to collect information on individual cases of ‘off-label’ use if there is no...
Read More >
6th Jun
Q&As

In summary, what is the current position regarding product liability in the life sciences sector?

In summary, what is the current position regarding product liability in the life sciences sector?The following Practice Notes are useful when...
Read More >
5th Jun
Q&As

How does the General Data Protection Regulation affect the pharmacovigilance sector?

How does the General Data Protection Regulation affect the pharmacovigilance sector?Pharmacovigilance (PV) is the practice of monitoring the effects...
Read More >
Produced in partnership with Rishi Wadwha of International Association of Privacy Professionals 5th Jun
Q&As

Is there any prohibition against the subcontracting of QPPV services?

Is there any prohibition against the subcontracting of QPPV services?The Guideline on good pharmacovigilance practices (GVP) (PV Guidance) provides...
Read More >
5th Jun
Q&As

Are there any requirements to monitor medicines once they have been authorised and placed on the market?

Are there any requirements to monitor medicines once they have been authorised and placed on the market?All medicinal products in the EU are subject...
Read More >
5th Jun
Precedents

Product recall clause

Product recall clause1Product recall clause—pro-supplier1.1The Customer shall immediately notify the Supplier if it becomes aware of any complaint or...
Read More >
Produced in partnership with Emma Spence of DWF LLP and David Kidman of DWF LLP 5th Jun
Practice notes

Defective products

Defective productsThis Practice Note summarises the law on defective products under the Consumer Protection Act 1987 (CPA 1987) and Council Directive...
Read More >
Produced in partnership with Alison Newstead of Shook, Hardy & Bacon International LLP, Simon Castley of Shook, Hardy & Bacon International LLP and Marisa Pearce of Shook, Hardy & Bacon International LLP 5th Jun

Popular documents

Contract variation

Contract variation

Contract variationThis Practice Note summarises the law, guidance and practice relating to the variation of contracts and deeds. It explains how a contract or deed can be varied in writing, orally or by conduct, and also considers unilateral variation, waiver and sustained minor breach. It sets out

Voluntary manslaughter

Voluntary manslaughter

Voluntary manslaughterVoluntary manslaughterVoluntary manslaughter consists of those killings which would be murder (because the accused has the relevant mental element for murder) but which are reduced to manslaughter because of one of the three special defences (loss of control, diminished

Tort—the different types of tort

Tort—the different types of tort

Tort—the different types of tortThis Practice Note identifies the main torts (bar negligence and nuisance, which are covered elsewhere in our related content) and their key characteristics. Specifically:•trespass to land•trespass to the person•privacy/defamation•liability for animals•employers'

Public inquiry procedure

Public inquiry procedure

Public inquiry procedureThe procedure by which a public inquiry is conducted will vary significantly from one inquiry to the next. Even for inquiries established under the Inquiries Act 2005 (IA 2005), the associated inquiry rules are not particularly prescriptive as to how they ought to be